WaferGen Bio-systems to Announce Second Quarter 2016 Financial Results on Tuesday, August 9

FREMONT, Calif., Aug. 2, 2016 /PRNewswire/ -- WaferGen Bio-systems, Inc. (NASDAQ: WGBS) announced today that it will announce second quarter ended June 30, 2016, financial results after the market close and host a conference call and webcast on Tuesday, August 9, 2016.

About WaferGen
WaferGen Bio-systems, Inc. is a biotechnology company that offers innovative genomic technology solutions for single-cell analysis and clinical research.  The ICELL8™ Single-Cell System is a cutting edge platform which can isolate thousands of single cells and processes specific cells for analysis, including Next Generation Sequencing ("NGS").  The system has demonstrated unbiased isolation of up to 1,800 single cells ranging from 5-100 µm in size on a single chip, including single cells from solid tumors, brain cells, pulmonary airway cells, and multiple cell lines.  The SmartChip™ platform can be used for profiling and validating molecular biomarkers, and can perform massively parallel singleplex PCR for one-step target enrichment and library preparation for clinical NGS.  The Apollo 324™ system can be used to process DNA and RNA from clinical samples to NGS-ready libraries.  These technologies offer a powerful set of tools for biological analysis at the molecular and single cell level in the life sciences, pharmaceutical, and clinical laboratory industries. 

INVESTOR CONTACT:
WaferGen Bio-systems, Inc.
Rollie Carlson
510-277-3417
[email protected]

SOURCE WaferGen Bio-systems, Inc.